SCHEMBL4557761

SCHEMBL4557761

O=C(NCC(O)C[AsH]c1ccc(N2CCOCC2=O)c(F)c1)c1ccc(Cl)s1

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.62
F2 P00734 2/20 0.50
ABCB11 O95342 1/20 0.50
ST14 Q9Y5Y6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77290 0.86 F10 (0.63) F10F2ABCB11ST14
SCHEMBL4557762 0.81 F10 (0.41) F10F2
SCHEMBL2989830 0.81 F10 (0.58) F10F2ABCB11ST14
SCHEMBL2989829 0.81 F10 (0.58) F10F2ABCB11ST14
SCHEMBL2191033 0.79 F10 (0.63) F10F2ABCB11ST14
SCHEMBL2191043 0.79 F10 (0.63) F10F2ABCB11ST14
SCHEMBL78973 0.79 F10 (0.62) F10F2ABCB11ST14
SCHEMBL78814 0.78 F10 (0.62) F10F2ABCB11ST14
SCHEMBL76937 0.78 F10 (0.71) F10F2ABCB11ST14
SCHEMBL80372 0.78 F10 (0.66) F10F2ABCB11ST14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099453-A2 COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES Bayer Schering Pharma Aktiengesellschaft (DE) 2009-09-16 EP disclosed
WO-2008052671-A2 COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-05-08 WO disclosed